# Optimum Misoprostol Dose Prior to Office Hysteroscopy

> **NCT01612065** · PHASE3 · COMPLETED · sponsor: **Cairo University** · enrollment: 132 (actual)

## Conditions studied

- Infertility
- Abnormal Uterine and Vaginal Bleeding, Unspecified
- Recurrent Abortion

## Interventions

- **DRUG:** Misoprostol
- **DRUG:** Misoprostol

## Key facts

- **NCT ID:** NCT01612065
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-03
- **Final completion:** 2013-04
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2013-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01612065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01612065, "Optimum Misoprostol Dose Prior to Office Hysteroscopy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01612065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*